Drs. Leora Horn, Ben Solomon, & Jack West assess whether clinical factors such as being a never-smoker or having a driver mutation (EGFR, ALK, etc.) reliably predict minimal benefit from immunotherapy agents.
Do Clinical Characteristics Alter Your Enthusiasm for Immune Checkpoint inhibitors_ [360p]
